F
#Exelixis #Oncology #Cabozantinib
www.fool.com
Exelixis (EXEL) Q4 2025 Earnings Call Transcript
Tuesday, February 10, 2026 at 5:00 p. m. ET
Call participants
* President and Chief Executive Officer -- Michael Morrissey
* Chief Financial Officer -- Christopher Senner
* Executive Vice President, Research & Development -- Dana Aftab
* Executive Vice President, Commercial -- Patrick Joseph Haley
Need a quote from a Motley Fool analyst.